This tax time, you can help protect the futures of young people facing breast cancer.

“Doctors could say to some patients, ‘based on this test and your type of breast cancer, we know we don’t need to put you through chemotherapy’.” – Dr Belinda Kiely, OPTIMA-Young Study Chair

This is the extraordinary promise of the OPTIMA-Young clinical trial. Friend, please help to raise $500,000 by 30 June to make this exciting research a reality.

Your support could help transform the lives of young people like Angela, who was diagnosed with hormone receptor (HR) positive breast cancer at just 38.

Chemotherapy took a devastating toll – robbing her of energy, health and precious time with loved ones. It also forced her to make painful decisions about her fertility. Two years on, Angela still feels the impacts of her treatment on her life.

Imagine sparing another young person like Angela from the pain, fear, and life-altering side effects that come with chemotherapy. Imagine sparing a daughter, partner, mum, granddaughter – or someone close to your heart.

This is the difference your gift can make Friend.

The OPTIMA-Young clinical trial could make a test available to identify which young people with early-stage, HR positive breast cancer can be safely spared chemotherapy – without compromising their survival.

Friend, this tax time, please donate to the research that could give thousands of young people each year, like Angela, kinder ways to survive breast cancer.